Hungary | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Hungary totalled $ 8.46 billion in 2023. Sales of commodity group 30 from Hungary went up by 20% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 1.44 billion (cumulative exports of commodity group 30 from Hungary amounted $7.01 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 5.35% of total exports from Hungary (cumulative merchandise exports from Hungary totalled $ 158 billion in 2023). The share of commodity group 30 in total exports from Hungary increased by 0.67 p.p. compared to 2022 (it was 4.68% in 2022 and cumulative exports from Hungary were equal to $ 149 billion).
Where does Hungary export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Hungary in 2023:
- Poland with a share of 11% (931 million US$)
- Romania with a share of 9.71% (821 million US$)
- Germany with a share of 8.09% (685 million US$)
- Czech Republic with a share of 7.51% (636 million US$)
- France with a share of 7.14% (604 million US$)
- Russia with a share of 5.83% (493 million US$)
- Italy with a share of 4.73% (400 million US$)
- Slovenia with a share of 4.61% (390 million US$)
- United Kingdom with a share of 3.93% (333 million US$)
- Ukraine with a share of 3.31% (280 million US$)
Exports structure of 30 - Pharmaceutical products - from Hungary in 2023 represented by the following main commodity groups:
- 54% (4.64 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 29% (2.46 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 11.8% (1 billion US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 3.46% (293 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.726% (61 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0% (77 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Hungary totalled $ 6.1 billion in 2023. Sales of commodity group 30 to Hungary went up by 18.5% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 956 million (the value of imports of commodity group 30 to Hungary was equal to $5.14 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 4.09% of total import flow to Hungary (in 2023, total imports to Hungary amounted to $ 148 billion). The share of commodity group 30 in total imports to Hungary increased by 0.868 p.p. compared to 2022 (it was 3.23% in 2022 and cumulative imports to Hungary were equal to $ 159 billion).
Where does Hungary import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Hungary in 2023:
- Netherlands with a share of 15.7% (961 million US$)
- Germany with a share of 13.8% (842 million US$)
- Belgium with a share of 11% (676 million US$)
- Korea with a share of 9.35% (570 million US$)
- France with a share of 7.57% (462 million US$)
- Ireland with a share of 4.87% (297 million US$)
- Singapore with a share of 4.67% (285 million US$)
- USA with a share of 3.96% (241 million US$)
- Poland with a share of 3.2% (195 million US$)
- Italy with a share of 2.99% (182 million US$)
Imports structure of 30 - Pharmaceutical products - to Hungary in 2023 represented by the following main commodity groups:
- 46% (2.82 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 41% (2.52 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 4.71% (288 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 4.14% (253 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.86% (113 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.76% (107 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
